ClinicalTrials.gg
CompletedNCT03875170Updated Jan 27, 2020

Proprioceptive Neuromuscular Facilitation in the Flexibility and Strength of Flexor Muscles and Hamstrings

An interventional study of Experimental and Control in Proprioceptive Disorders, sponsored by Investigación en Hemofilia y Fisioterapia. Completed at 1 site in Spain. Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-01-27.

Sponsored by Investigación en Hemofilia y Fisioterapia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

Introduction: The loss of normal values of ROM due to the lack of flexibility and strength in the hip flexors, quadriceps and hamstrings in soccer players can cause a loss of mobility of the hip and knee joint. Proprioceptive neuromuscular facilitation is an active-assisted stretching technique used to improve flexibility and therefore the ranges of joint mobility.

Aim. To assess the effectiveness of an intervention by proprioceptive neuromuscular facilitation in the improvement of flexibility and strength in the hamstring, hip flexor and quadriceps musculature compared to conventional stretches in football players.

Study design. Randomized, multicentric, single-blind clinical study. Methods. The 30 players will be randomly assigned to the study groups: experimental (proprioceptive neuromuscular facilitation and static stretches) and control (static stretches). The treatment will last 6 weeks, with two sessions a week of 5 minutes each. The study variables will be the range of hip mobility (using goniometry), hamstring flexibility (using the EPR test, inclinometer) and the strength of hip flexors, quadriceps and hamstrings (through the RM test). A descriptive statistical analysis will be carried out calculating the main statistical characteristics and after calculating the normality of the sample (test Kolmogorov- Smirnov), the differences between evaluations in each group (t-student test) and the intra- and intersubject effect will be calculated (ANOVA of repeated measures).

Expected results. Improved hip mobility, hamstring flexibility and strength in hip flexors, quadriceps and hamstrings muscles.

02

Conditions studied

  • Proprioceptive Disorders

Keywords

  • Proprioceptive Neuromuscular Facilitation
  • Range of motion
  • Stretching
  • Muscle strength
  • Randomized clinical trial
03

In context

Somatosensory Disorders

64 studies on the registry are indexed under Somatosensory Disorders; 8 are open to participants now.

This study's enrollment of 30 is below the median of 40 across 45 interventional studies indexed under Somatosensory Disorders.

Browse Somatosensory Disorders studies →

Lead sponsor

Investigación en Hemofilia y Fisioterapia is the lead sponsor of 57 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volleyball players
  • Male
  • From 18 to 30 years old
  • Federated in the Royal Federation of Football of the Community of Madrid
  • Not had any musculoskeletal injuries in the last 3 months.

Exclusion criteria

Exclusion Criteria:

  • Impossibility, for work or academic reasons, to comply with the requirements of the study (interventions and evaluations);
  • Under pharmacological treatment
  • Who are exercising a physiotherapy treatment parallel to the development of the study
  • Not sign the informed consent document.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Proprioceptive neuromuscular facilitation

    Each session will last 5 minutes for each subject, taking place two sessions a week, in a period of 6 weeks. The intervention will be made at the beginning of the training session. The technique will be carried out with the subjects in the positions of supine, prone and lateral position, for the flexor muscles of the hip, hamstrings and quadriceps, where the musculature and the joint to be treated will be taken to a range of functional mobility

    Other: Experimental

  • Active comparator
    Muscle stretching

    Each session will last 5 minutes for each subject, taking place two sessions a week, in a period of 6 weeks. The intervention will be made at the beginning of the training session. It will be done for the hip, quadriceps and hamstring muscles with a voluntary antagonist activation to relax the agonist muscle.

    Other: Control

Interventions

  • OtherExperimental

    The technique will be carried out with the subjects in the positions of supine, prone and lateral position, for the flexor muscles of the hip, hamstrings and quadriceps, where the musculature and the joint to be treated will be taken to a range of functional mobility. The subject will be asked to perform an isometric contraction, with a series of 3 seconds for sustained contraction and a rest between contraction of 2 to 3 seconds after activating the Golgi apparatus, making an inhibition of the stimulus and bringing the joint and muscle to the highest possible range of motion without pain.

    Also known as: Proprioceptive neuromuscular facilitation

  • OtherControl

    The active stretching technique will be performed for the hip, quadriceps and hamstring flexors with a voluntary antagonist activation to relax the agonist muscle, holding the movement to be performed for 30 seconds to stimulate the neuromuscular spindle and produce a relaxation of the muscle fibers.

    Also known as: Muscle stretching

06

What researchers measure

Primary outcomes

  1. Change from baseline flexibility of the hamstring muscles after treatment and at month

    The measurement instrument to measure the flexibility of the hamstring muscles is the passive elevation of the straight leg with an inclinometer (model ISOMED, Inc., Portland, OR) to be placed on the tibia (as distal as possible). The physiotherapist will maintain the extension of the knee and the leg will be lifted by the evaluator to a hip flexion, until the subject indicates pain in the hamstring muscles, when the evaluator perceives hip flexion restriction or when a posterior pelvic tilt occurs. The contralateral knee of the subject will remain in extension. The unit of measurement of the test is the maximum angle read from the inclinometer at the point of maximum flexibility, in degrees, with the normative range of 75 to 80 degrees (the greater the degree of flexibility, the greater the flexibility).

    Time frame: Screening visit, within the first seven days after treatment and after one month follow-up visit

Secondary outcomes

  1. Change from baseline the range of motion of hip after treatment and at month

    The range of motion of the hip will be evaluated using a universal long arm goniometer. The hip flexion will be measured with the goniometer as the deviation from the neutral zero position in which the lower extremity and the trunk are in the horizontal plane. The fixed arm of the goniometer will be aligned on the horizontal axis of the body, while the mobile arm of the goniometer will be aligned on the lateral midline of the thigh, placing the goniometer support axis on the greater trochanter. Hip adduction and hip abduction will be measured from the neutral zero position in which the longitudinal axis of the thigh is perpendicular to the transverse line through the anterior superior iliac spines of the pelvis. The contralateral leg will be hanging over the edge of the stretcher. The unit of measurement for this test is the grade, with a range of normative movement from 0 to 50 degrees (the higher the graduation, the greater the mobility of the hip).

    Time frame: Screening visit, within the first seven days after treatment and after one month follow-up visit

  2. Change from baseline strength of upper limbs after treatment and at month

    The strength of upper limbs will be measured with the 1RM test. This test is defined as the maximum repetition with the heaviest load through a full range of motion. To calculate the 1 RM, the indirect relationship methods of lifting a submaximal load with a full range of motion to failure will be used. From this action a mathematical model related to the load and the number of repetitions until the failure will be made, obtaining a value of force. The unit of measurement of this evaluation is the kilogram (a higher value indicates a greater performance in the strength of lower limbs)

    Time frame: Screening visit, within the first seven days after treatment and after one month follow-up visit

07

Study locations

1 site
  • European University of Madrid
    Madrid, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03875170
Lead sponsor
Investigación en Hemofilia y Fisioterapia
Responsible party
Sponsor
First posted
Mar 14, 2019
Start date
Apr 12, 2019
Primary completion
May 15, 2019
Completion
Jun 20, 2019
Last update
Jan 27, 2020

Study contacts

Rubén Cuesta-Barriuso, PhD
principal investigator · Universidad Europea de Madrid

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion